
(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Vote In favor of Your Number one Savvy Beds - 2
Without evidence, CDC changes messaging on vaccines and autism - 3
RFK Jr.'s diet guidelines emphasize red meat, full-fat dairy. How healthy are they? - 4
What loving-kindness meditation is and how to practice it in the new year - 5
UN rights chief says Israeli policy in West Bank 'resembles apartheid system'
Independence from the rat race: How to Save and Contribute Shrewdly
The 2026 'Super Bowl of Astronomy' starts today — here's what's happening
Watch interstellar comet 3I/ATLAS make its closest approach to Earth in free livestream on Dec. 18
Vote in favor of Your Number one Cake Type
Senior's Manual for Obtaining a Hyundai Ioniq EV: Tips
All that You Really want to Be aware of Dental Inserts Facilities
Tickets for 'Stranger Things' Season 5 finale, to be shown in movie theaters on New Year's Eve, go on sale today. Here's how you can save your seat.
23 Most Amusing Messages At any point Sent Among Kids and Their Folks
EU Council president: Ukraine should receive binding guarantees












